Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Cheng-Der Yu"'
Autor:
Ming-Tain Lai, Cheng-Der Yu, Jiann-Shiun Lai, Nan-Hsuan Wang, Yueh-Chin Wu, Chi-Huan Lu, Hui-Wen Chang, Yu-Jung Chen, Teng-Yi Huang, I-Ju Chen, Chun-Chung Wang, Wan-Fen Li, Chi-Sheng Shia, Ming-Chen Yang
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcba16014f579e89354c9b3b53f5503c
https://doi.org/10.1158/1535-7163.22522797
https://doi.org/10.1158/1535-7163.22522797
Autor:
Ming-Tain Lai, Cheng-Der Yu, Jiann-Shiun Lai, Nan-Hsuan Wang, Yueh-Chin Wu, Chi-Huan Lu, Hui-Wen Chang, Yu-Jung Chen, Teng-Yi Huang, I-Ju Chen, Chun-Chung Wang, Wan-Fen Li, Chi-Sheng Shia, Ming-Chen Yang
Supplementary Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec703d5b83c795ac018834b8be04b3f
https://doi.org/10.1158/1535-7163.22522800
https://doi.org/10.1158/1535-7163.22522800
Autor:
Cheng-Der Yu, Hui-Wen Chang, Chi-Sheng Shia, Teng-Yi Huang, Jiann-Shiun Lai, Yueh-Chin Wu, I-Ju Chen, Wan-Fen Li, Yu-Jung Chen, Nan-Hsuan Wang, Chun-Chung Wang, Chi-Huan Lu, Ming-Tain Lai, Ming-Chen Yang
Publikováno v:
Molecular cancer therapeutics. 20(6)
Globo H (GH), a hexasaccharide, is expressed at low levels in normal tissues but is highly expressed in multiple cancer types, rendering it a promising target for cancer immunotherapy. OBI-999, a novel antibody–drug conjugate, is derived from a con
Autor:
Hemanshu S. Shah, Bhiku Patel, Pamela Pasciak, Kirk J. Leister, Linda M. Kozick, Cheng-Der Yu, Roger K. Vanderlaan, Elizabeth L Tan
Publikováno v:
Pharmaceutical Research. 10:1238-1242
The selection of an ideal semisolid vehicle for growth factors presents a challenge. Some antimicrobial agents are known to delay wound healing. The objective of this investigation was to identify appropriate preservatives and vehicles for TGF-α. Cr
Autor:
Jennifer S. Degroot, Cheng-Der Yu, Sriram Vemuri, Seresh Venkataram, Vuthichai Wangsatornthnakun
Publikováno v:
Drug Development and Industrial Pharmacy. 17:327-348
Various sugars were investigated for their ability to protect liposomes against fusion and leakage during freeze-and-thaw or lyophilization processes. Size of liposome was measured before and after the events with a light scattering technique. Leakag
Publikováno v:
Drug Development and Industrial Pharmacy. 17:183-192
An in vitro method was developed to determine the rate of drug release from a liposome formulation. Liposome formulation containing metaproterenol sulfate was evaluated for release of the drug over a 24-hour period in an end-over-end tumbler device.
Publikováno v:
Drug Development and Industrial Pharmacy. 16:1579-1584
An in vitro method of interaction of liposome vesicles with high density lipoproteins (HDL) was studied. A formulation of lipids was hydrated, and homogenized with a high shear mixer and designed as “unsized” liposomes. A portion of this preparat
Publikováno v:
Drug Development and Industrial Pharmacy. 16:2243-2256
Liposomes can be produced by a variety of techniques such as sonication, high-pressure homogenization, detergent dialysis, reverse-phase evaporation and ether injection. The Microfluidizer is a high-pressure homogenizer which is capable of making sma
Publikováno v:
Drug Development and Industrial Pharmacy. 15:609-620
RS-82856 is a new inotropic agent for treatment of congestive heart failure. Oral bioavailability was found to be very poor likely due to insufficient aqueous solubility (∼ 4.4 mcg/ml) and slow dissolution rate. Inclusion complexes with cyclodextri
Publikováno v:
Journal of Pharmaceutical Sciences. 68:1347-1357
Results of initial studies on methods for determining various model parameters are reported. By employing excised hairless mouse skin in a diffusion cell system, numerous model parameter values were deduced. The stratum corneum permeability was estim